Please Wait...

About

Bioclinica is a specialty clinical trial services provider that accelerates the development of new medical therapies.

Clinical trials are a complex undertaking. While there are many companies available to support trials, many offer a monolithic approach—one that is massive, indivisible, and rigid. These methods tend to focus on the system and not on your needs.

Bioclinica puts your objectives first. We understand that the fundamental purpose of a clinical trial is to discover the truth. The ability to see key details and uncover hidden insights will help you find the truth quickly and efficiently.

That's why Bioclinica has built an expert, multifaceted organization that brings clarity to clinical trials. We help you see more clearly, so you can make better decisions.

Strong Sites

providing high-quality data and superior patient recruitment and retention methods

Agile Technology

systems and domain expertise to reveal data insights and speed drug development

Scientific Experts

who can see more deeply into biomarker data and identify things others might miss

400
Clients Includes Top 100 Pharma & Top 10 CROs
135
Drugs Approved by the FDA Using Imaging and Biomarkers
4000
Clinical Trials Supported
2800
Employees Worldwide
30
Years of Experience

Bioclinica Solves Critical Pain Points For Trial Sponsors and CROs

Bioclinica leverages its therapeutic and clinical expertise, technology, data analytics and deep customer experience to solve key industry challenges. By bringing together key functional areas of clinical trial support, Bioclinica solves a variety of critical pain points that can hinder clinical trials.

Clinical development process is long and expensive

Solution: Reduce time to market, decrease the number of patients required, improve measurement precision, and enhance sponsor ability to identify efficacy and safety earlier in a trial

Clinical trial imaging is non-standardized and complex

Solution: Train and qualify trial sites to ensure data standardization; navigate logistics of digitally collecting, processing, and storing images from multi-country trials across dozens or hundreds of sites

Paper-based processes and legacy software are inefficient

Solution: Software solutions accelerate data collection, analysis, and feedback from clinical trials. Investigator payment solution eliminates payer errors and streamlines payment process globally

Recruitment is #1 cause of trial delays

Solution: A multifaceted "patient engagement" approach employing digital marketing strategies, patient communities, and databases accelerates recruitment and improves retention

Regulations and surveillance related to adverse events

Solution: High-quality safety case management and regulatory submission services utilizing cost effective resources and technology solutions

Large investigator site networks are inefficient

Solution: Site network provides local knowledge, physician access, and an extensive patient database, yielding rapid access to large eligible patient populations and improved retention rates

More About Bioclinica

MANAGEMENT

A dedicated team of clinical trial experts with years of experience.
LEARN MORE

CAREERS

Want to change the future of clinical trials? This is the place.
LEARN MORE

Offices

With offices in North America, Europe, and Asia, our company is global but service is local.
LEARN MORE

COMMUNITY OUTREACH

Giving back to the communities where we do business.
LEARN MORE

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Our Medical Imaging team is in the spotlight for a job well done! https://t.co/fkmt0zvPhf https://t.co/D7YMTeiSd3
bioclinica (2 days ago)
RT @melfass: "What this agreement means is that we can allocate scarce resources to areas of higher risk" @US_FDA on MRA with @EMA_News at…
bioclinica (3 days ago)
RT @DrugInfoAssn: What has been the biggest takeway for your organization so far? Tweet @ us using #DIA2017
bioclinica (5 days ago)
"Q" on #RBM & Total Quality Mgmt? @Kristin_Mauri has "A" @DrugInfoAssn #DIA2017 https://t.co/MqCxkmAfa0
bioclinica (5 days ago)
Kristen Mauri shows the @DIA audience the value of risk based monitoring https://t.co/ssJCfc9gQ5
bioclinica (5 days ago)
Innovation Theater Kristin Mauri of @bioclinica presenting on RBM & TQM @DrugInfoAssn #DIA2017 https://t.co/zsGroQcpiU
bioclinica (5 days ago)

Latest Blogs: